Top Markets
Coin of the day
Nutra Pharma Corp. Nutra Pharma Corp.

Nutra Pharma Corp.

NPHC
Clasificación en acciones #38964
Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in... Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic, and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.
Precio por acción
$0.0001
Capitalización bursátil
$715.97K
Cambio (1 día)
0.00%
Cambio (1 año)
-50.00%
País
US
Comercio Nutra Pharma Corp. (NPHC)

Categoría

Historial del precio de la acción de Nutra Pharma Corp. (NPHC)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $100.68 el 2001-12-01
Historial del precio de la acción de Nutra Pharma Corp. desde 2001 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 648.94%
2024 11.90%
2023 -62.35%
2022 -87.53%
2021 58.96%
2020 169.20%
2019 15.03%
2018 -37.56%
2017 -94.29%
2016 -86.13%
2015 -68.46%
2014 -38.63%
2013 -35.75%
2012 -87.51%
2011 19.51%
2010 -73.66%
2009 1,628.44%
2008 -32.58%
2007 -71.51%
2006 -34.09%
2005 -37.06%
2004 -55.68%
2003 58.98%
2002 -84.39%
2001 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$161.14 24.66%
DE
$36.61 23.93%
JP
$224.67 38.51%
CH
$21.30 13.79%
IN